Shah NL - Search Results

1

Coagulation testing and management in liver disease patients.

Stotts MJ, Davis JPE, Shah NL. Stotts MJ, et al. Among authors: shah nl. Curr Opin Gastroenterol. 2020 May;36(3):169-176. doi: 10.1097/MOG.0000000000000635. Curr Opin Gastroenterol. 2020. PMID: 32141899 Review.

2

The role of anti-fibrinolytics, rFVIIa and other pro-coagulants: prophylactic versus rescue?

Shah NL, Caldwell SH, Berg CL. Shah NL, et al. Clin Liver Dis. 2009 Feb;13(1):87-93. doi: 10.1016/j.cld.2008.09.005. Clin Liver Dis. 2009. PMID: 19150313

3

Immunosuppressed solid organ transplant recipient.

Stine JG, Shah N, Argo C. Stine JG, et al. Gastroenterology. 2014 Feb;146(2):345,590. doi: 10.1053/j.gastro.2013.09.045. Epub 2013 Dec 14. Gastroenterology. 2014. PMID: 24342810 No abstract available.

4

Procoagulant therapeutics in liver disease: a critique and clinical rationale.

Shah NL, Intagliata NM, Northup PG, Argo CK, Caldwell SH. Shah NL, et al. Nat Rev Gastroenterol Hepatol. 2014 Nov;11(11):675-82. doi: 10.1038/nrgastro.2014.121. Epub 2014 Jul 15. Nat Rev Gastroenterol Hepatol. 2014. PMID: 25023035 Review.

5

Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease.

DeAngelis GA, Khot R, Haskal ZJ, Maitland HS, Northup PG, Shah NL, Caldwell SH. DeAngelis GA, et al. Among authors: shah nl. J Vasc Interv Radiol. 2016 Nov;27(11):1665-1674. doi: 10.1016/j.jvir.2016.05.039. Epub 2016 Aug 29. J Vasc Interv Radiol. 2016. PMID: 27595469 Review.

6

Reply to: "Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease".

DeAngelis GA, Khot R, Haskal ZJ, Maitland HS, Northup PG, Shah NL, Caldwell SH. DeAngelis GA, et al. Among authors: shah nl. J Vasc Interv Radiol. 2017 Jun;28(6):922-923. doi: 10.1016/j.jvir.2017.04.001. J Vasc Interv Radiol. 2017. PMID: 28532752 No abstract available.

7

Therapeutic options for bleeding oesophageal varices: cyanoacrylate and balloon-occluded retrograde obliteration (BRTO).

Frischtak HL, Davis JP, Shah NL. Frischtak HL, et al. Among authors: shah nl. BMJ Case Rep. 2017 Aug 11;2017:bcr2017219615. doi: 10.1136/bcr-2017-219615. BMJ Case Rep. 2017. PMID: 28801510 Free PMC article.

8

Reply to: "Re: Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease".

DeAngelis GA, Khot R, Haskal ZJ, Maitland HS, Northup PG, Shah NL, Caldwell SH. DeAngelis GA, et al. Among authors: shah nl. J Vasc Interv Radiol. 2017 Sep;28(9):1337-1338. doi: 10.1016/j.jvir.2017.07.015. J Vasc Interv Radiol. 2017. PMID: 28841962 No abstract available.

9

Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference.

Intagliata NM, Argo CK, Stine JG, Lisman T, Caldwell SH, Violi F; faculty of the 7th International Coagulation in Liver Disease. Intagliata NM, et al. Thromb Haemost. 2018 Aug;118(8):1491-1506. doi: 10.1055/s-0038-1666861. Epub 2018 Jul 30. Thromb Haemost. 2018. PMID: 30060258 Free PMC article. No abstract available.

10

Thrombocytopenia in Chronic Liver Disease and the Role of Thrombopoietin Agonists.

Miller JB, Figueroa EJ, Haug RM, Shah NL. Miller JB, et al. Among authors: shah nl. Gastroenterol Hepatol (N Y). 2019 Jun;15(6):326-332. Gastroenterol Hepatol (N Y). 2019. PMID: 31391802 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters